Closure of guide wire-induced coronary artery perforation with a two-component fibrin glue.
Perforation or rupture of a coronary artery with subsequent pericardial effusion and cardiac tamponade is a potentially life-threatening complication of percutaneous coronary intervention (PCI). Several emergency treatment strategies exist to close the perforation including reversal of anticoagulation, prolonged balloon inflation, implantation of stent grafts, local injection of thrombogenic molecules, placement of microcoils, or open heart surgery. Here we report on a 66-year-old patient who underwent urgent PCI for acute stent thrombosis in the proximal LAD. The artery was reopened, a new stent implanted successfully, and a GPIIb/IIIa-antagonist was given. Shortly thereafter the patient suffered from cardiac tamponade requiring pericardiocentesis and pericardial drainage. The coronary angiogram indicated a severe guide wire-induced perforation and pericardial effusion originating from a distal diagonal branch segment. Prolonged balloon inflation did not stop the leakage. Therefore the monorail balloon was exchanged for an over-the-wire balloon. A two-component commercial fibrin glue consisting of fibrinogen and thrombin was rapidly but separately injected through the wire channel of the balloon into the distal segment of the diagonal branch. The coronary leak was successfully closed and the patient recovered quickly. In comparison with the previously reported cases of thrombin injection important differences should be noticed: (1) a two-component hemostatic seal was used without reversal of anticoagulation, (2) rapid injection instead of prolonged infusion of the hemostatic drugs was performed, and (3) the rescue technique was applied in a cath lab that routinely uses monorail catheter systems. Therefore we consider this a novel and effective approach for closure of coronary ruptures.
Störger
Hans
H
Red Cross Hospital Cardiology Center, Frankfurt, Germany.
Ruef
Johannes
J
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D002305:Cardiac Tamponade / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D017023:Coronary Angiography; D003331:Coronary Vessels / Q000293:injuries*; D004322:Drainage; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage*; D006335:Heart Injuries / Q000150:complications / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D006489:Hemostatic Techniques; D006801:Humans; D007267:Injections; D008297:Male; D010490:Pericardial Effusion / Q000150:complications* / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy; D014014:Tissue Adhesives / Q000008:administration & dosage*; D016896:Treatment Outcome
D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives